| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/17/1997 | EP0812591A1 Injectable compositions containing Nimesulide |
| 12/17/1997 | EP0812589A1 Combined antipyretic analgesic drug |
| 12/17/1997 | EP0812588A1 External preparation |
| 12/17/1997 | EP0812587A1 Transdermal compositions containing Nimesulide |
| 12/17/1997 | EP0812411A1 Freeze-drying process and apparatus |
| 12/17/1997 | EP0812235A1 Method for making granules, and resulting granules |
| 12/17/1997 | EP0812214A1 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| 12/17/1997 | EP0812213A1 Gel form of a vaccine |
| 12/17/1997 | EP0812212A1 Compositions for the delivery of antigens |
| 12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
| 12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/17/1997 | EP0812199A1 Sphingosine, methylsphingosine and apoptosis |
| 12/17/1997 | EP0812195A1 Pharmaceutical composition for piperidinoalkanol compounds |
| 12/17/1997 | EP0812187A1 Redispersible nanoparticulate film matrices with protective overcoats |
| 12/17/1997 | EP0812186A1 Method for loading lipid vesicles |
| 12/17/1997 | EP0695172B1 High release solid preparation, preparation and use thereof |
| 12/17/1997 | EP0651649B1 Granulocyte colony-stimulating factor solution delivery method |
| 12/17/1997 | EP0616528B1 Implantable capsule |
| 12/17/1997 | EP0593601B1 Novel compositions based on taxane class derivatives |
| 12/17/1997 | EP0591311B1 Controlled release systems and low dose androgens |
| 12/17/1997 | CN2270505Y Long-acting Chinese medicinal herb plaster for curing kidney disease |
| 12/17/1997 | CN1168102A Resin particle, medical material and pharmaceutical preparation contg. said resin particle |
| 12/17/1997 | CN1168095A Treatment of attention-deficit/hyperactivity disorder |
| 12/17/1997 | CN1168094A Directly compressible high load acetaminophen formulations |
| 12/17/1997 | CN1036699C Silica ketoconazole ointment and its preparing method |
| 12/16/1997 | US5698677 Stable preparation for the treatment of blood coagulation disorders |
| 12/16/1997 | US5698661 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices |
| 12/16/1997 | US5698590 Treatment of peripheral circulatory disorders and ulcers and for blood flow maintenance after surgery |
| 12/16/1997 | US5698589 Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
| 12/16/1997 | US5698582 Injectable solution; dissolved in polysorbate or polyethoxylated castor oil; ethanol-free |
| 12/16/1997 | US5698562 Consisting of trimethoprim, purified water, hydrochloric acid to dissolve drug, sucrose, flavoring to overcome bitter taste; pediatric dosing |
| 12/16/1997 | US5698536 Plasma-like substance |
| 12/16/1997 | US5698535 SIN-1A cyclodextrin inclusion complexes |
| 12/16/1997 | US5698533 Mixing warm water with a hydrocarbonaceous semi-solid or oil containing a drug, atomizing and applying to the eye in the form of liquid drops; eliminates the need for chloroflurocarbon propellants |
| 12/16/1997 | US5698531 Delivering a dna sequence encoding a therapeutic or diagnostic protein by catheterization to a discrete blood vessel segment using genetically engineered or normal cells or vector systems; drug delivery |
| 12/16/1997 | US5698529 Chemotherapeutic compositions |
| 12/16/1997 | US5698524 Preparing water soluble reaction product polymer of lignin and lignoid that have each been extracted from wood or wood-like materials under acidic and/or alkaline conditions |
| 12/16/1997 | US5698271 Methods for the manufacture of magnetically responsive particles |
| 12/16/1997 | US5698226 Water-dispersible tablets |
| 12/16/1997 | US5698225 A core of nonsteroidal anti-inflammatory antiarthritic agent surrounded by coatings comprising misoprostol an anti-ulcer agent for side effect reduction; drug delivery |
| 12/16/1997 | US5698224 Osmotic dosage form |
| 12/16/1997 | US5698221 Containing 2-amino-2-(4-methylpiperazin-1-ylzzzz0-5-(2,3,5-trichlorophen yl)pyrimidine |
| 12/16/1997 | US5698220 Controlled drug release by diffusion or osmotic pumping |
| 12/16/1997 | US5698219 Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof |
| 12/16/1997 | US5698217 Transdermal drug delivery device containing a desiccant |
| 12/16/1997 | US5698216 Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof |
| 12/16/1997 | US5698214 Prevent glucose transfer into cells |
| 12/16/1997 | US5698213 Hydrogels of absorbable polyoxaesters |
| 12/16/1997 | US5698211 Stabilized agchemical concentrate and use thereof |
| 12/16/1997 | US5698207 Burn treatment composition |
| 12/16/1997 | US5698119 Apparatus for forming dispenser delivery ports |
| 12/16/1997 | US5697922 Asymmetric membrane, osmotic, delivery device having coated macroparticulate solubility modifiers |
| 12/16/1997 | US5697901 Gene delivery by microneedle injection |
| 12/16/1997 | CA2109623C Process for solubilizing difficultly soluble pharmaceutical actives |
| 12/16/1997 | CA2066249C Estradiol percutaneous administration preparations |
| 12/11/1997 | WO1997046860A2 Improvements in detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046667A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 12/11/1997 | WO1997046592A1 Substantially uncrosslinked carboxymethyl starch, process for the preparation thereof, use as a retarding agent and a retarding drug |
| 12/11/1997 | WO1997046262A2 Membrane incorporation of texaphyrins |
| 12/11/1997 | WO1997046241A1 Formulation and method for treating congestive heart failure |
| 12/11/1997 | WO1997046224A1 Enteric coating, comprising alginic acid, for an oral preparation |
| 12/11/1997 | WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 12/11/1997 | WO1997046222A1 Pediatric formulation for hiv protease inhibitors |
| 12/11/1997 | WO1997046205A2 Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products |
| 12/11/1997 | WO1997046118A1 Dietetic foods containing conjugated linoleic acids |
| 12/11/1997 | WO1997046104A1 Treatment of diarrhea |
| 12/11/1997 | WO1997041843A3 Medicated chewing gum with a pleasant taste containing an inclusion complex |
| 12/11/1997 | WO1997039107A3 Methods for increasing the maturation of cells |
| 12/11/1997 | WO1997038677A3 Freeze-dried liposome delivery system for application of skin treatment agents |
| 12/11/1997 | DE19623916A1 3 betaÝN-(N,N'-di:methyl aminoethane)-carbamoyl¨cholesterol |
| 12/11/1997 | DE19622790A1 Nahezu unvernetzte Carboxymethylstärke, Verfahren zu deren Herstellung, Verwendung dieser modifizierten Stärke als Retardierungsmittel sowie eine retardierende Arzneimittelzusammensetzung Virtually non-crosslinked carboxymethyl starch, methods for their preparation, use of this modified starch as retarding agent and a sustained-release drug composition |
| 12/11/1997 | DE19612349A1 Production of multi-phase liquids, emulsions and suspensions |
| 12/11/1997 | CA2258907A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 12/11/1997 | CA2257225A1 Membrane incorporation of texaphyrins |
| 12/11/1997 | CA2256720A1 Formulation and method for treating congestive heart failure |
| 12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | CA2254716A1 Dietetic foods containing conjugated linoleic acids |
| 12/11/1997 | CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 12/10/1997 | EP0811664A1 Coating composition and uses in food industry and in pharmaceutical industry |
| 12/10/1997 | EP0811381A1 A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof |
| 12/10/1997 | EP0811376A1 Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases |
| 12/10/1997 | EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine |
| 12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
| 12/10/1997 | EP0810975A2 Method of producing hydrophilic or partially hydrophilic inorganic aerogels |
| 12/10/1997 | EP0810880A1 Pharmaceuticals and assays using enzyme subunits |
| 12/10/1997 | EP0810868A1 Use of piperine as a bioavailability enhancer |
| 12/10/1997 | EP0810865A1 Novel pharmaceutical composition |
| 12/10/1997 | EP0810863A1 Method of treating adenosine depletion |
| 12/10/1997 | EP0810857A1 Colonic drug delivery composition |
| 12/10/1997 | EP0810856A2 Banded prolonged release active agent dosage form |
| 12/10/1997 | EP0810855A1 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 12/10/1997 | EP0810854A1 Aerosols containing beclomethazone nanoparticle dispersions |
| 12/10/1997 | EP0810853A1 Aerosols containing nanoparticle dispersions |
| 12/10/1997 | EP0810823A1 Composition for controlling parasites |
| 12/10/1997 | EP0810822A1 Use of aerogels in agriculture |
| 12/10/1997 | EP0781135A4 Codeine containing formulations |
| 12/10/1997 | EP0706374B1 Method for preparing liposomes |
| 12/10/1997 | EP0684808B1 Light stable color compositions |
| 12/10/1997 | CN1167441A New Therapeutical utilization of superoxide dismutases |